GRAIL, Inc. SEC filings GRAL

GRAIL, Inc. has 265 filings in SEC EDGAR's recent list, going back to Mar 14, 2017. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

GRAIL, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Mar 12, 2026 —
424B5 Prospectus supplement Nov 14, 2025 —
424B7 Filing Nov 13, 2025 —
S-3ASR Automatic shelf registration Nov 13, 2025 —
S-8 Employee stock plan registration May 14, 2025 —
S-8 Employee stock plan registration Mar 5, 2025 —
S-8 Employee stock plan registration Aug 30, 2024 —
S-8 Employee stock plan registration Jun 21, 2024 —
S-1/A Amended registration statement Sep 17, 2020 —
S-1 Registration statement Sep 9, 2020 —

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
GRAL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Sunnyvale, CA
SEC filer status
, Emerging growth company
SEC CIK
1699031
Former names
GRAIL, LLC (until Jun 12, 2024)

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.